Literature DB >> 1280243

Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis.

C C Hsia1, R P Evarts, H Nakatsukasa, E R Marsden, S S Thorgeirsson.   

Abstract

Proliferation of a new population of epithelial cells with distinct structure, as well as cytokeratin and alpha-fetoprotein expression, was observed in nonneoplastic liver tissues from 14 cases (13 hepatitis B virus-positive) of human hepatocellular carcinoma. These cells were characterized by oval nuclei; scant, pale cytoplasm; small cell size; and cross-reaction with a monoclonal antibody against rat oval cells. These putative human oval cells were strongly positive for cytokeratin 19 and displayed considerable heterogeneity in alpha-fetoprotein and albumin expression. The oval cells were most prominent in actively regenerating nodules and in liver tissue surrounding the cancer. Oval cells and transitional types of cells appear to be the principal producers of alpha-fetoprotein in the regenerating liver. Cancer cells positive for cytokeratins 8, 18 and 19 were observed in half the hepatocellular carcinomas studied. The data suggest that a new cell population structurally similar to oval cells seen in early stages of chemical hepatocarcinogenesis in rats is consistently present in regenerating liver lesions associated with human hepatocellular carcinoma. Furthermore, it is possible that the proliferation of these oval-type cells may partly account for the elevation of serum alpha-fetoprotein frequently seen in precancerous stages of hepatitis B virus-associated human hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280243     DOI: 10.1002/hep.1840160604

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  39 in total

Review 1.  Hepatic stem cells.

Authors:  A J Strain; H A Crosby
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  The facultative stem cell: A new star in liver pathology.

Authors:  Peter Nagy
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

3.  Stem cell technology. Interview by Abi Berger.

Authors:  P A Fontes; A W Thomson
Journal:  BMJ       Date:  1999-11-13

Review 4.  Stem cells in hepatocarcinogenesis: evidence from genomic data.

Authors:  Jens U Marquardt; Snorri S Thorgeirsson
Journal:  Semin Liver Dis       Date:  2010-02-19       Impact factor: 6.115

5.  Possible stem cell origin of human cholangiocarcinoma.

Authors:  Chao Liu; Jie Wang; Qing-Jia Ou
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 6.  Environmental exposures, stem cells, and cancer.

Authors:  Tasha Thong; Chanese A Forté; Evan M Hill; Justin A Colacino
Journal:  Pharmacol Ther       Date:  2019-07-31       Impact factor: 12.310

7.  The CD133+CD44+ precancerous subpopulation of oval cells is a therapeutic target for hepatocellular carcinoma.

Authors:  Yun-Wen Zheng; Tomonori Tsuchida; Taiki Shimao; Bin Li; Takanori Takebe; Ran-Ran Zhang; Yu Sakurai; Yasuharu Ueno; Keisuke Sekine; Naoto Ishibashi; Makiko Imajima; Takuji Tanaka; Hideki Taniguchi
Journal:  Stem Cells Dev       Date:  2014-06-26       Impact factor: 3.272

Review 8.  Clinical implications of cancer stem cell biology in hepatocellular carcinoma.

Authors:  Junfang Ji; Xin Wei Wang
Journal:  Semin Oncol       Date:  2012-08       Impact factor: 4.929

Review 9.  Functional and genetic deconstruction of the cellular origin in liver cancer.

Authors:  Jens U Marquardt; Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

10.  Progenitor-derived hepatocellular carcinoma model in the rat.

Authors:  Jesper B Andersen; Roberto Loi; Andrea Perra; Valentina M Factor; Giovanna M Ledda-Columbano; Amedeo Columbano; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.